The largest database of trusted experimental protocols

Recombinant human insulin

Manufactured by Roche
Sourced in Germany

Recombinant human insulin is a laboratory-produced insulin that is structurally and functionally identical to the insulin produced naturally by the human body. It is a protein-based molecule that plays a critical role in regulating blood sugar levels. The core function of recombinant human insulin is to facilitate the uptake and utilization of glucose by cells, thereby maintaining normal blood sugar levels.

Automatically generated - may contain errors

14 protocols using recombinant human insulin

1

Adipogenic Differentiation of ASCs

Check if the same lab product or an alternative is used in the 5 most similar protocols
Adipogenic differentiation of culture-expanded, and scaffold-seeded non-GFP-Tg ASC or GFP-Tg ASC was performed over a 15 day period as previously described4 (link). Briefly, cultured ASC were grown in Stromal Medium (Dulbecco’s modified Eagle’s-Ham’s F-12 medium supplemented with 10% fetal bovine serum, and 1% penicillin/streptomycin). ASC were then trypsinized and plated in 24-well plates in ASC culture media at 3×104 cells/cm2 for 24 hrs to allow attachment. On day 1 (24 hours after plating), the medium was removed and cells were incubated for three days in adipogenic differentiation medium (Dulbecco’s modified Eagle’s-Ham’s F-12 medium supplemented with 10% fetal bovine serum, 15 mM HEPES (pH 7.4), biotin (33 µM), pantothenate (17 µM, Sigma), human recombinant insulin (100 nM, Boehringer Mannheim), dexamethasone (1 µM), 1-methyl-3-isobutylxanthine (IBMX; 0.25 mM), and rosiglitazone (1 µM). For the remaining 9 days of the adipocyte differentiation maintenance period, the medium was removed every 3 days and replaced with the same medium that did not contain IBMX and rosiglitazone (maintenance medium).
+ Open protocol
+ Expand
2

Adipogenic Differentiation of ASCs

Check if the same lab product or an alternative is used in the 5 most similar protocols
Adipogenic differentiation of ASCs was performed as previously described [49] (link). Briefly, ASCs were cultured in ASC growth medium until the culture reached 90–95% confluency. ASCs were then trypsinized and plated in 24-well plates in ASC growth medium at 30,000 cells/cm2 for 24 hrs. to allow attachment. On day 1 (24 hours after plating), the medium was removed and cells were incubated for three days in ASC adipogenic differentiation medium [Dulbecco's modified Eagle's-Ham's F-12 medium supplemented with 3% or 10% FBS, 15 mM HEPES (pH 7.4), biotin (33 µM), pantothenate (17 µM, Sigma), human recombinant insulin (100 nM, Boehringer Mannheim), dexamethasone (1 µM), 1-methyl-3-isobutylxanthine (IBMX; 0.25 mM), and rosiglitazone (1 µM)]. For the remaining 9 days of the adipocyte differentiation maintenance period, the medium was removed every 3 days and replaced with the same medium that did not contain IBMX and rosiglitazone (maintenance medium). Adipocyte differentiated conditioned medium (ADCM) was collected on day 6 after the switch to ASC adipogenic differentiation medium and stored at 4°C until use.
+ Open protocol
+ Expand
3

Adipogenic Differentiation of GFP-Tg ASCs on Silk Scaffolds

Check if the same lab product or an alternative is used in the 5 most similar protocols
For scaffold seeded GFP-Tg SVF cells and GFP-Tg ASC, one day prior to seeding, scaffolds were autoclaved and pre-soaked in adipogenic medium in 37°C, 5% CO2, 95% relative humidity. GFP-Tg ASC were then trypsinized and plated loaded onto pre-soaked scaffolds in ASC adipogenic differentiation media by pipet in two aliquots of 50 µL each containing a total of 2.5 × 105 cells to opposite faces of a cylindrical HFIP silk scaffold as per published methods33 (link). The cells were incubated for three days in adipogenic differentiation medium (Dulbecco’s modified Eagle’s-Ham’s F-12 medium supplemented with 10% fetal bovine serum, 15 mM HEPES (pH 7.4), biotin (33 µM), pantothenate (17 µM, Sigma), human recombinant insulin (100 nM, Boehringer Mannheim), dexamethasone (1 µM), 1-methyl-3-isobutylxanthine (IBMX; 0.25 mM), and rosiglitazone (1 µM). For the remaining 9 days of the adipocyte differentiation maintenance period, the medium was removed every 3 days and replaced with the same medium that did not contain IBMX and rosiglitazone (maintenance medium). Similarly, control cultures were maintained in parallel in the absence of adipogenic stimulants. All seeded and nonseeded (control) scaffolds were cultivated in a humidified incubator at 37°C with 5% CO2. Following the in vitro cultivation period, seeded scaffolds were evaluated for their extent of adipogenesis.
+ Open protocol
+ Expand
4

Insulin Formulations and Kinase Inhibitors

Check if the same lab product or an alternative is used in the 5 most similar protocols
phenol (CAS No.108-95-2) and m-cresol (CAS No. 108-39-4) were obtained from Sigma–Aldrich. Jun N-terminal kinase (JNK) inhibitor SU3327 (10–20 μM in dimethyl sulfoxide (DMSO)) and p38 Inhibitor SB202190 (1–2 μM in DMSO) were from Tocris Bioscience.
The following formulations of insulin or insulin analogs were used, each at 100 I.U./ml: Apidra (3.15 mg/ml m-cresol, Sanofi-Aventis), Insuman Infusat (2.7 mg/ml phenol, Sanofi-Aventis), Humalog (3.15 mg/ml m-cresol, Eli Lilly), NovoRapid (1.72 mg/ml m-cresol and 1.5 mg/ml phenol, Novo Nordisk). Recombinant human insulin (Roche Diagnostics GmbH) was dissolved in phosphate buffer at 3 mg/ml (equivalent to 100 U/ml).
+ Open protocol
+ Expand
5

Glucose and Insulin Tolerance Tests

Check if the same lab product or an alternative is used in the 5 most similar protocols
For GTT, mice were fasted for 14 h and injected with D-glucose (2 g kg−1 BW or 2.5 g kg−1 LM) (Sigma) intraperitoneally. For ITT, mice were fasted for 4 h and injected with recombinant human insulin (1 U kg−1, Roche) intraperitoneally.
+ Open protocol
+ Expand
6

Erythroid Differentiation from Human iPSCs

Check if the same lab product or an alternative is used in the 5 most similar protocols
Human iPSC passages 9–20 were grown in Matrigel (BD)-coated dishes supplemented with mTeSR media (STEMCELL Technologies). The protocol for erythroid induction was adapted from a study by Kobari et al. (2012) (link). For all subjects, the cultures were started with approximately 107 cells. Human iPSCs were differentiated by formation of EBs (hEB) during 27 d in a liquid culture medium on the basis of IMDM (Biochrom), 450 µg/ml holo human transferrin (Sigma-Aldrich), 10 µm g/ml recombinant human insulin (Roche), 2 IU/ml heparin, and 5% human plasma in the presence of 100 ng/ml SCF, 100 ng/ml TPO, 100 ng/ml FLT3 ligand, 10 ng/ml rhu bone morphogenetic protein 4 (BMP4), 5 ng/ml rhu VEGF (VEGF-A165), 5 ng/ml IL-3, 5 ng/ml IL-6 (PeproTech), and 3 U/ml Epo. Terminal differentiation was achieved by further culturing in sequential combination of cytokines as described by Kobari et al. (2012) (link)
+ Open protocol
+ Expand
7

Recombinant β2m Expression and Purification

Check if the same lab product or an alternative is used in the 5 most similar protocols
β2m was expressed in Escherichia coli BL21(DE3) and purified as previously described (73 (link)). The purity of the protein solution was confirmed to be more than 95% by SDS-PAGE and MALDI-TOF mass spectroscopy (Bruker Daltonics). Recombinant human insulin was purchased from Roche Diagnostics GmbH, and ThT was from FUJIFILM Wako Pure Chemical Corporation. All other reagents were obtained from Nacalai Tesque.
+ Open protocol
+ Expand
8

Evaluation of Biologically Active Compounds

Check if the same lab product or an alternative is used in the 5 most similar protocols
Compound 48/80, vespid mastoparan, rocuronium, tubocurarine, ciprofloxacin, levofloxacin, moxifloxacin, and ofloxacin were from Sigma. Cortistatin was from Tocris Biosciences. PAMP (9-20) was custom synthesized and purified to ≥98% by Genscript. Leuprolide was from Genscript. Substance P, kallidin, mastoparan, cetrorelix, octreotide, sermorelin (growth hormone releasing factor 1-29), icatibant (HOE-140) were from Anaspec. Atracurium and mivacurium were from Santa Cruz Biotechnology. Recombinant human insulin was from Roche. Goat anti-mouse IgE (Ab9162) was from Abcam.
+ Open protocol
+ Expand
9

Insulin Quantification Protocol

Check if the same lab product or an alternative is used in the 5 most similar protocols
HT (≥98% purity) was obtained from Cayman Chemicals (Ann Arbor, MI, USA). Recombinant human insulin was from Roche Diagnostics (Mannheim, Germany). All other chemicals were obtained from Sigma Aldrich (St. Louis, MO, USA), unless otherwise indicated.
+ Open protocol
+ Expand
10

Glucose and Insulin Tolerance Tests in Mice

Check if the same lab product or an alternative is used in the 5 most similar protocols
Mice were fasted overnight and a glucose tolerance test (GTT) was performed after an injection of glucose (2 g/kg body weight, i.p.). Blood glucose concentrations were measured using a OneTouch glucometer (LifeScan, Canada) both before (0 min) and after (30, 60, and 120 min) the glucose injections. For the insulin tolerance test (ITT), mice were fasted for 12 h and injected with recombinant human insulin (Roche, 0.75 U/kg body weight, i.p.). Glucose levels were measured both before (0 min) and after (15, 30, 60, and 90 min) the insulin injections. The area under the curve (AUC) was calculated by applying the trapezoidal rule (Xuan et al., 2018 (link)).
Plasma Ang1-7 concentration was evaluated using an Ang1-7 ELISA kit (Bio-Swamp, MU30979, China).
+ Open protocol
+ Expand

About PubCompare

Our mission is to provide scientists with the largest repository of trustworthy protocols and intelligent analytical tools, thereby offering them extensive information to design robust protocols aimed at minimizing the risk of failures.

We believe that the most crucial aspect is to grant scientists access to a wide range of reliable sources and new useful tools that surpass human capabilities.

However, we trust in allowing scientists to determine how to construct their own protocols based on this information, as they are the experts in their field.

Ready to get started?

Sign up for free.
Registration takes 20 seconds.
Available from any computer
No download required

Sign up now

Revolutionizing how scientists
search and build protocols!